REFERENCES
- Kuczmarski R., Flegal K., Campbell S, Johnson C. Increasing Prevalence of Overweight Among US Adults. JAMA 1994; 272: 205–11
- National Task Force on the Prevention and Treatment of Obesity, Long-term Pharmacotherapy in the Management of Obesity. JAMA 1996; 270: 1907–15
- Food and Drug Administration, Endocrinologic and Metabolic Drugs Advisory Committee Transcript of September 28. 1995; 345–9
- Weintraub M. Long-term Weight Control Study: Conclusions. Clin Pharmacol Ther 1992; 51: 642–6
- Rubin L J. Primary Pulmonary Hypertension. N Engl J Med 1997; 336: 111–7
- McCann U D., Seiden L. S., Rubin L. J., Ricaurte G. A. Brain Serotonin Neurotoxicity and Primary Pulmonary Hypertension From Fenfluramine and Dexfenfluramine: A Systemic Review of the Evidence. JAMA 1997; 278: 666–72
- Redux Prescribing Information. Wyeth-Ayerst Laboratories. April, 1996. Wyeth-Ayerst, Philadelphia
- Jick H., Vasilakis C., Weinrauch L., Meier C. R., Jick S. S., Derby L. E. A Population-Based Study of Appetite-Suppressant Drugs and the Risk of Cardiac-Valve Regurgitation. N Engl J Med 1998; 339: 719–24
- Gilbert D. L, Franko B. V., Ward J. W., Woodard G., Courtney K. D. Toxicologic Studies of Fenfluramine. Toxicol Applied Pharmacol 1971; 19: 705–11
- Vial T., Robert E, Carlier P., Bertolotti E., Brun A. First Trimester In Utero Exposure to Anorectics: A French Collaborative Study With Special Reference to Dexfenfluramine. Int J Risk Saf Med 1992; 3: 207–14
- Rayburn W., Christensen H., Sienko A., Gonzalez C., Coleman F. Antenatal Betamethasone for Fetal Lung Maturation: Selection of a Murine Model to Investigate Long-Term Neurobehavioral Effects. Neurotoxicol Teratol 1996; 18: 329
- Rayburn W., Christensen H., Gonzalez C. A Placebo-Controlled Comparison Between Betamethasone and Dexamethasone for Fetal Maturation: Differences on Neurobehavior in Mice Offspring. Am J Obstet Gynecol 1997; 176: 842–51
- Harwood P. D. Therapeutic Dosage in Small and Large Mammals. Science 1963; 139: 684–5
- Manson A. M., Kang Y. J. Best Methods for Assessing Female Reproductive and Developmental Toxicology. Principals and Methods of Toxicology, A. W. Hayes. Raven Press, New York 1994; 989–1037
- Rayburn W. The Mouse as a Model to Investigate Long-Term Effect From Prenatal Exposure to centrally Acting Drugs. J Mat Fetal Invest 1997; 7: 3–6
- Santon M. E. Workshop on the Qualitative and Quantitative Comparability of Human and Animal Developmental Neurotoxicity, Work Group 1 Report: Comparability of Measures of Developmental Neurotoxicity in Humans and Laboratory Animals. Neurotoxical Teratol 1990; 12: 2617–22
- Marchant N. C., Breen M., Wallace D., Bass S., Taylor A. R., Ings R. M., Campbell D. B, Williams S. J. Comparative Biodisposition and Metabolism of 14 c – (+/−) – Fenfluramine in Mouse, Rat, Dog, and Man. Xenobiotica 1997; 22: 1261–66
- Vorhees C., Branner R., Butcher R. Psychotropic Drugs as Behavior Teratogens. Science 1979; 205: 1220–5